{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:43:58Z","timestamp":1778960638977,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009458","name":"American Pharmacists Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.japh.2019.04.021","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T17:43:51Z","timestamp":1561398231000},"page":"S72-S76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S","title":["Assessing barriers to patient acceptance of pharmacist-provided recommendations for international travel"],"prefix":"10.1016","volume":"59","author":[{"given":"Raisa","family":"El-Kurdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy D.","family":"Sauls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Selinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Taylor","family":"Schimmelfing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann N.","family":"Chelminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine S.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macary Weck","family":"Marciniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2019.04.021_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/fampra\/cmu063","article-title":"Travel-associated disease among US residents visiting US GeoSentinel clinics after return from international travel","volume":"31","author":"Hagmann","year":"2014","journal-title":"Fam Pract"},{"key":"10.1016\/j.japh.2019.04.021_bib2","first-page":"1","article-title":"Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011","volume":"62","author":"Harvey","year":"2013","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.japh.2019.04.021_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5455\/msm.2012.24.131-134","article-title":"Common health risks, required precautions of travelers and their customs towards the use of travel medicine services","volume":"24","author":"Roupa","year":"2012","journal-title":"Mater Sociomed"},{"key":"10.1016\/j.japh.2019.04.021_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1708-8305.2010.00470.x","article-title":"A\u00a0comparison of pharmacist travel-health specialists\u2019 versus primary care providers\u2019 recommendations for travel-related medications, vaccinations, and patient compliance in a college health setting","volume":"18","author":"Durham","year":"2011","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.japh.2019.04.021_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/00365548.2014.896030","article-title":"Travel health advice: benefits, compliance, and outcome","volume":"46","author":"Angelin","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.japh.2019.04.021_bib6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2146\/ajhp050430","article-title":"Development and clinical outcomes of pharmacist-managed diabetes care clinics","volume":"63","author":"Morello","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.japh.2019.04.021_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1331\/JAPhA.2015.14140","article-title":"Evaluating health outcomes following a pharmacist-provided comprehensive pretravel health clinic in a supermarket pharmacy","volume":"55","author":"Tran","year":"2015","journal-title":"J\u00a0Am Pharm Assoc"},{"key":"10.1016\/j.japh.2019.04.021_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jtm.12183","article-title":"Immediate recall of health issues discussed during a pre-travel consultation","volume":"22","author":"McGuinness","year":"2015","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.japh.2019.04.021_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/cid\/cir839","article-title":"Global TravEpiNet: a national consortium of clinics providing care to international travelers\u2014analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009\u20132011","volume":"54","author":"LaRocque","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.japh.2019.04.021_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.japh.2017.12.004","article-title":"Pharmacists\u2019 scope of practice in travel health: a review of state laws and regulations","volume":"58","author":"Hurley-Kim","year":"2018","journal-title":"J\u00a0Am Pharm Assoc"},{"key":"10.1016\/j.japh.2019.04.021_bib11","first-page":"1","article-title":"Pharmacy-based travel health services in the United States","volume":"7","author":"Hurley-Kim","year":"2019","journal-title":"Pharmacy"},{"key":"10.1016\/j.japh.2019.04.021_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12879-016-1682-0","article-title":"Travelers\u2019 health problems and behavior: prospective study with post-travel follow-up","volume":"16","author":"Vilkman","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.japh.2019.04.021_bib13","author":"Kenny"},{"key":"10.1016\/j.japh.2019.04.021_bib14","first-page":"94","article-title":"Strategies for addressing and overcoming vaccine hesitancy","volume":"94","author":"Loehr","year":"2016","journal-title":"Am Fam Physician"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119302092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119302092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:45:39Z","timestamp":1761543939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319119302092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1544319119302092"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2019.04.021","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing barriers to patient acceptance of pharmacist-provided recommendations for international travel","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2019.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}